9th Annual Biomarkers Congress

Allan D'Arcy

TypeWhite Paper Summary

The Novartis Institute for Tropical Diseases aims to discover novel treatments and prevention methods for major tropical diseases. In those developing countries where these diseases are endemic, the Novartis Group intends to make treatments readily available and without profit to poor patients. The discovery technology is state-of-the-art and the scope of activities range from target discovery through to screen development and compound optimization up to readiness for clinical testing.

The Institute is looking to recruit the best scientists in the world, and as a major center of excellence, will offer exceptional teaching and training opportunities for post-doctoral fellows and graduate students.

Keywords
Authors
Name:D'Arcy Allan
Organizations
Organization:Novartis Pharmaceuticals

Previous Comments

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.